\-\ Texto\\:\\ \ \(0\)\
\-\ eye\\ examination\\:\ \(0\)\
\-\ \\ \\-\\ va\\:\\ nlp\\ od\\,\\ 20\\/20\\ os\ \(0\)\
\-\ \\ \\-\\ iop\\:\\ 19\\ mm\\ od\\,\\ 19\\ mm\\ os\ \(0\)\
\-\ \\ \\-\\ ptosis\\ and\\ inflammation\\ rul\ \(0\)\
\-\ \\ \\-\\ severe\\ proptosis\ \(0\)\
\-\ \\ \\-\\ chemosis\\ and\\ injection\\ od\ \(0\)\
\-\ \\ \\-\\ hard\\ nodule\\ over\\ rlg\\ and\\ rul\ \(0\)\
\-\ ocular\\ examination\\:\ \(0\)\
\-\ \\ \\-\\ palpebral\\ fissures\\:\\ 10\\ mm\\ od\\,\\ 8\\ mm\\ os\ \(0\)\
\-\ \\ \\-\\ hertel\\ ex\\:\\ 28\\ mm\\ od\\,\\ 10\\ mm\\ os\ \(0\)\
\-\ \\ \\-\\ pupillary\\ ex\\:\\ 3\\-4\\ mm\\ pup\\ defect\\ od\ \(0\)\
\-\ \\ \\-\\ fundus\\:\\ complete\\ on\\ atrophy\ \(0\)\
\-\ general\\ examination\\:\ \(0\)\
\-\ \\ \\-\\ normal\\ neurologic\\ examination\ \(0\)\
\-\ \\ \\-\\ normal\\ chest\\ x\\-ray\ \(0\)\
\-\ \\ \\-\\ no\\ lymphadenopathy\ \(0\)\
\-\ \\ \\-\\ no\\ skin\\ melanoma\ \(0\)\
\-\ management\\:\ \(3\)\
\-\ \\ \\-\\ anterior\\ orbitotomy\\:\\ multinodular\\,\\ bluish\\ pigmentation\\,\\ bony\\ erosion\ \(0\)\
\-\ \\ \\-\\ orbital\\ exenteration\\;\\ partial\\ removal\\ of\\ frontal\\ and\\ temporal\\ bones\\;\\ craniotomy\\.\ \(0\)\
\-\ folow\\ up\\:\ \(0\)\
\-\ \\ \\-\\ patient\\ died\\ of\\ acute\\ myocardial\\ infarction\\,\\ one\\ month\\ after\\ second\\ surgery\\.\ \(0\)\
\-\ \\ \\-\\ autopsy\\:\\ metastatic\\ melanoma\\,\\ lower\\ lobe\\,\\ right\\ lung\\.\ \(0\)\
\-\ head\\ mri\\:\ \(0\)\
\-\ \\ \\-\\ \\‚\\Ä\\ú\\ the\\ lacrimal\\ lesion\\ demonstrates\\ a\\ heterogenous\\ pattern\\ of\\ enhancement\\ and\\ is\\ low\\ signal\\ on\\ t1\\.\ \(0\)\
\-\ \\ \\-\\ the\\ posterior\\ orbital\\ lesion\\ has\\ more\\ homogenous\\ pattern\\ of\\ enhancement\\ with\\ low\\ t1\\ signal\\.\ \(0\)\
\-\ \\ \\-\\ the\\ intracranial\\ portion\\ demonstrates\\ hi\\ t1\\ signal\\ which\\ is\\ not\\ fat\\ and\\ enhances\\ mildly\\.\ \(0\)\
\-\ \\ \\-\\ this\\ could\\ represent\\ calcification\\,\\ blood\\ products\\,\\ melanin\\,\\ or\\ mucinous\\ material\\‚\\Ä\\ù\ \(0\)\
\-\ primary\\ malignant\\ melanoma\\ of\\ orbit\ \(0\)\
\-\ 50\\ yom\ \(0\)\
\-\ \\ \\-\\ proptosis\ \(0\)\
\-\ \\ \\-\\ tearing\ \(0\)\
\-\ \\ \\-\\ visual\\ loss\ \(0\)\
\-\ \\ \\-\\ swollen\\ right\\ eye\ \(0\)\
\-\ \\ \\-\\ painless\\ to\\ painful\ \(0\)\
\-\ \\ \\-\\ 8\\ ms\ \(1\)\
\-\ pmh\\:\\ arthritis\\,\\ hypercholesterolemia\\.\ \(0\)\
\-\ fh\\:\\ great\\ grandfather\\ was\\ blind\\ \\(cause\\ unknown\\.\\ maternal\\ grandfather\\ had\\ colon\\ cancer\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ \\-\\:\\ 0\\.19674120482423163\ \(0\)\
\-\ od\\:\\ 0\\.1316699259126741\ \(0\)\
\-\ mm\\:\\ 0\\.0814643188798705\ \(0\)\
\-\ os\\:\\ 0\\.07558439047795838\ \(0\)\
\-\ \\:\\:\\ 0\\.06697924835500238\ \(0\)\
\-\ grandfather\\:\\ 0\\.05202784410917365\ \(0\)\
\-\ melanoma\\:\\ 0\\.04845745697458878\ \(0\)\
\-\ ex\\:\\ 0\\.04753794926791206\ \(0\)\
\-\ rul\\:\\ 0\\.04476244223501272\ \(0\)\
\-\ examination\\:\\ 0\\.03935441534036393\ \(0\)\
\-\ proptosis\\:\\ 0\\.03535160856394036\ \(0\)\
\-\ rlg\\:\\ 0\\.03265006823691296\ \(0\)\
\-\ pup\\:\\ 0\\.03265006823691296\ \(0\)\
\-\ folow\\:\\ 0\\.03265006823691296\ \(0\)\
\-\ t1\\:\\ 0\\.030094394846936042\ \(0\)\
\-\ hertel\\:\\ 0\\.030082856457061307\ \(0\)\
\-\ orbitotomy\\:\\ 0\\.030082856457061307\ \(0\)\
\-\ orbital\\:\\ 0\\.030024773993842534\ \(0\)\
\-\ 19\\:\\ 0\\.02918756370937294\ \(0\)\
\-\ nlp\\:\\ 0\\.028581133834438475\ \(0\)\
\-\ palpebral\\:\\ 0\\.028581133834438475\ \(0\)\
\-\ hi\\:\\ 0\\.028581133834438475\ \(0\)\
\-\ eye\\:\\ 0\\.02655118375638453\ \(0\)\
\-\ bluish\\:\\ 0\\.026013922054586826\ \(0\)\
\-\ exenteration\\:\\ 0\\.026013922054586826\ \(0\)\
\-\ iop\\:\\ 0\\.02544299361078217\ \(0\)\
\-\ pigmentation\\:\\ 0\\.02544299361078217\ \(0\)\
\-\ yom\\:\\ 0\\.02544299361078217\ \(0\)\
\-\ signal\\:\\ 0\\.025034159225253098\ \(0\)\
\-\ pattern\\:\\ 0\\.024195869178305764\ \(0\)\
\-\ va\\:\\ 0\\.02412197529989797\ \(0\)\
\-\ melanin\\:\\ 0\\.02412197529989797\ \(0\)\
\-\ fh\\:\\ 0\\.02412197529989797\ \(0\)\
\-\ 20\\/20\\:\\ 0\\.02376897463395603\ \(0\)\
\-\ chemosis\\:\\ 0\\.02376897463395603\ \(0\)\
\-\ 8\\:\\ 0\\.023667537468513692\ \(0\)\
\-\ pupillary\\:\\ 0\\.023446710274735178\ \(0\)\
\-\ hypercholesterolemia\\:\\ 0\\.023150255801870228\ \(0\)\
\-\ multinodular\\:\\ 0\\.02238122111750636\ \(0\)\
\-\ autopsy\\:\\ 0\\.02238122111750636\ \(0\)\
\-\ tearing\\:\\ 0\\.022156685481149192\ \(0\)\
\-\ ptosis\\:\\ 0\\.02194498765211235\ \(0\)\
\-\ lacrimal\\:\\ 0\\.021554763520046323\ \(0\)\
\-\ fissures\\:\\ 0\\.021374059208307684\ \(0\)\
\-\ 10\\:\\ 0\\.02133795724701415\ \(0\)\
\-\ maternal\\:\\ 0\\.019931597109190194\ \(0\)\
\-\ blind\\:\\ 0\\.01981400933765471\ \(0\)\
\-\ myocardial\\:\\ 0\\.019377775872260698\ \(0\)\
\-\ ocular\\:\\ 0\\.019177526904593012\ \(0\)\
\-\ craniotomy\\:\\ 0\\.018987551740194675\ \(0\)\
\-\ mucinous\\:\\ 0\\.018987551740194675\ \(0\)\
\-\ homogenous\\:\\ 0\\.018806847428456036\ \(0\)\
\-\ products\\:\\ 0\\.018806847428456036\ \(0\)\
\-\ 3\\-4\\:\\ 0\\.018551318274800662\ \(0\)\
\-\ died\\:\\ 0\\.018551318274800662\ \(0\)\
\-\ fundus\\:\\ 0\\.01831228671503188\ \(0\)\
\-\ low\\:\\ 0\\.017601244836047403\ \(0\)\
\-\ hard\\:\\ 0\\.017424609480715506\ \(0\)\
\-\ great\\:\\ 0\\.01724679755780306\ \(0\)\
\-\ enhancement\\:\\ 0\\.01696658345276323\ \(0\)\
\-\ ms\\:\\ 0\\.01691490067376718\ \(0\)\
\-\ swollen\\:\\ 0\\.016862364988611787\ \(0\)\
\-\ atrophy\\:\\ 0\\.016328885839637944\ \(0\)\
\-\ heterogenous\\:\\ 0\\.016239635648604388\ \(0\)\
\-\ erosion\\:\\ 0\\.015984106494949014\ \(0\)\
\-\ orbit\\:\\ 0\\.01594318117573944\ \(0\)\
\-\ painless\\:\\ 0\\.015902703136731325\ \(0\)\
\-\ pmh\\:\\ 0\\.01574507493518023\ \(0\)\
\-\ painful\\:\\ 0\\.015044178640222719\ \(0\)\
\-\ \\;\\:\\ 0\\.015003119914463658\ \(0\)\
\-\ enhances\\:\\ 0\\.014949610855018404\ \(0\)\
\-\ 28\\:\\ 0\\.014918617337720196\ \(0\)\
\-\ injection\\:\\ 0\\.014767424765422954\ \(0\)\
\-\ visual\\:\\ 0\\.014347688893915534\ \(0\)\
\-\ x\\-ray\\:\\ 0\\.014269162198913301\ \(0\)\
\-\ material\\:\\ 0\\.014141874630379197\ \(0\)\
\-\ represent\\:\\ 0\\.013899716262739005\ \(0\)\
\-\ demonstrates\\:\\ 0\\.013826823715949527\ \(0\)\
\-\ arthritis\\:\\ 0\\.013521231296455497\ \(0\)\
\-\ mildly\\:\\ 0\\.013479143301454331\ \(0\)\
\-\ inflammation\\:\\ 0\\.013458277309905235\ \(0\)\
\-\ lymphadenopathy\\:\\ 0\\.013458277309905235\ \(0\)\
\-\ intracranial\\:\\ 0\\.013375969395887788\ \(0\)\
\-\ bones\\:\\ 0\\.013355675078241027\ \(0\)\
\-\ general\\:\\ 0\\.013335491356879677\ \(0\)\
\-\ neurologic\\:\\ 0\\.013216645747429675\ \(0\)\
\-\ nodule\\:\\ 0\\.01304523555274817\ \(0\)\
\-\ \\,\\:\\ 0\\.013034188339721245\ \(0\)\
\-\ infarction\\:\\ 0\\.01293521646232626\ \(0\)\
\-\ lesion\\:\\ 0\\.012893001674077443\ \(0\)\
\-\ temporal\\:\\ 0\\.012673669917089396\ \(0\)\
\-\ bony\\:\\ 0\\.012656873046106465\ \(0\)\
\-\ partial\\:\\ 0\\.012656873046106465\ \(0\)\
\-\ removal\\:\\ 0\\.012476966860371067\ \(0\)\
\-\ colon\\:\\ 0\\.012429381147490147\ \(0\)\
\-\ unknown\\:\\ 0\\.012351405557868544\ \(0\)\
\-\ skin\\:\\ 0\\.012156033093477696\ \(0\)\
\-\ second\\:\\ 0\\.012156033093477696\ \(0\)\
\-\ 50\\:\\ 0\\.012040733394977054\ \(0\)\
\-\ management\\:\\ 0\\.01194270904983571\ \(0\)\
\-\ defect\\:\\ 0\\.011847212319629359\ \(0\)\
\-\ \\‚\\Ä\\ú\\:\\ 0\\.011820373769552445\ \(0\)\
\-\ \\‚\\Ä\\ù\\:\\ 0\\.01175411612232735\ \(0\)\
\-\ could\\:\\ 0\\.011676140532705749\ \(0\)\
\-\ calcification\\:\\ 0\\.011488094883174553\ \(0\)\
\-\ portion\\:\\ 0\\.011463728323552172\ \(0\)\
\-\ malignant\\:\\ 0\\.01143952102362704\ \(0\)\
\-\ complete\\:\\ 0\\.011138429385133534\ \(0\)\
\-\ cause\\:\\ 0\\.010708380098340615\ \(0\)\
\-\ cancer\\:\\ 0\\.010404315793943575\ \(0\)\
\-\ frontal\\:\\ 0\\.009941821979567991\ \(0\)\
\-\ normal\\:\\ 0\\.0099230552192526\ \(0\)\
\-\ severe\\:\\ 0\\.009738184444688904\ \(0\)\
\-\ fat\\:\\ 0\\.009625601195857902\ \(0\)\
\-\ month\\:\\ 0\\.009494868669631886\ \(0\)\
\-\ primary\\:\\ 0\\.009375497269984061\ \(0\)\
\-\ loss\\:\\ 0\\.009186904342475702\ \(0\)\
\-\ lung\\:\\ 0\\.009167256000884246\ \(0\)\
\-\ head\\:\\ 0\\.00897630115027369\ \(0\)\
\-\ blood\\:\\ 0\\.00863855952781222\ \(0\)\
\-\ one\\:\\ 0\\.008576782901150534\ \(0\)\
\-\ lobe\\:\\ 0\\.0085160198071242\ \(0\)\
\-\ up\\:\\ 0\\.00851054500390453\ \(0\)\
\-\ anterior\\:\\ 0\\.008151084532454583\ \(0\)\
\-\ over\\:\\ 0\\.008057935519036899\ \(0\)\
\-\ metastatic\\:\\ 0\\.00796707186524478\ \(0\)\
\-\ more\\:\\ 0\\.007915467812267284\ \(0\)\
\-\ acute\\:\\ 0\\.007814367885579612\ \(0\)\
\-\ surgery\\:\\ 0\\.00768518171985287\ \(0\)\
\-\ chest\\:\\ 0\\.007573070370583403\ \(0\)\
\-\ posterior\\:\\ 0\\.007294957587786847\ \(0\)\
\-\ mri\\:\\ 0\\.007271392055239333\ \(0\)\
\-\ lower\\:\\ 0\\.007118007664310602\ \(0\)\
\-\ had\\:\\ 0\\.006829073404595216\ \(0\)\
\-\ right\\:\\ 0\\.006678753400817901\ \(0\)\
\-\ after\\:\\ 0\\.006548152602256305\ \(0\)\
\-\ no\\:\\ 0\\.006373660375583718\ \(0\)\
\-\ has\\:\\ 0\\.005943333224052882\ \(0\)\
\-\ which\\:\\ 0\\.0059079429157131436\ \(0\)\
\-\ on\\:\\ 0\\.005362155647151319\ \(0\)\
\-\ not\\:\\ 0\\.004573402487933094\ \(0\)\
\-\ is\\:\\ 0\\.004165116876923894\ \(0\)\
\-\ and\\:\\ 0\\.004000200127382633\ \(0\)\
\-\ or\\:\\ 0\\.0037093435146803985\ \(0\)\
\-\ was\\:\\ 0\\.003660287119309951\ \(0\)\
\-\ this\\:\\ 0\\.0035597674567190113\ \(0\)\
\-\ patient\\:\\ 0\\.0031725627070977335\ \(0\)\
\-\ \\(\\:\\ 0\\.0026754138009031873\ \(0\)\
\-\ of\\:\\ 0\\.0021574777925553413\ \(0\)\
\-\ to\\:\\ 0\\.0015817337349740231\ \(0\)\
\-\ the\\:\\ 0\\.00153610316337362\ \(0\)\
\-\ a\\:\\ 0\\.0014688881548837085\ \(0\)\
\-\ \\.\\:\\ 0\\.001051838106588038\ \(0\)\
\-\ with\\:\\ 0\\.00043334880033292495\ \(0\)\
